copanlisib (aliqopa) Report issue

Small molecule Orphan Drug FDA Approved FDA First in Class Fast Track FDA Accelerated Approval FDA Priority Review FDA
AACT ChEMBL DrugBank Drugs@FDA MeSH PubChem

Back

Chemistry

Mol. Mass

553.45

ALogP

0.66

Rule of 5

No

Rule of 3

No
Details
  • SMILES: Cl.Cl.COc1c(OCCCN2CCOCC2)ccc3C4=NCCN4C(=Nc13)NC(=O)c5cnc(N)nc5
  • InChIKey: STGQPVQAAFJJFX-UHFFFAOYSA-N
    InChI=1S/C23H28N8O4.2ClH/c1-33-19-17(35-10-2-6-30-8-11-34-12-9-30)4-3-16-18(19)28-23(31-7-5-25-20(16)31)29-21(32)15-13-26-22(24)27-14-15;;/h3-4,13-14H,2,5-12H2,1H3,(H2,24,26,27)(H,28,29,32);2*1H
  • Chirality: Achiral Molecule
  • Inorganic: No
  • Polymer: No

Sources

CHEMBL3545068   ChEMBL
copanlisib hydrochloride *

CHEMBL3218576   ChEMBL
copanlisib

WI6V529FZ9   NCATS
copanlisib *

Copanlisib   Wikipedia

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue